Last reviewed · How we verify
NCT06011941
Modified Laparoscopic Transcystic Biliary Drainage in the Management of Cholecystocholedocholithiasis
NA trial testing Modified laparoscopic transcystic biliary drainage in Common Bile Duct Calculi in 310 participants. Not yet recruiting.
31 December 2026
Quick facts
| Lead sponsor | Peking University Third Hospital |
|---|---|
| Phase | NA |
| Status | Not yet recruiting |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 310 |
| Start date | 1 January 2024 |
| Primary completion | 31 December 2026 |
| Estimated completion | 1 July 2027 |
| Sites | 1 location across China |
Drugs / interventions tested
- Modified laparoscopic transcystic biliary drainage
Conditions studied
- Common Bile Duct Calculi — all drugs for Common Bile Duct Calculi →
- Acute; Cholecystitis, Choledocholithiasis — all drugs for Acute; Cholecystitis, Choledocholithiasis →
- Acute Cholecystitis With Obstruction — all drugs for Acute Cholecystitis With Obstruction →
- Acute Cholangitis — all drugs for Acute Cholangitis →
Sponsor
Peking University Third Hospital
Who can join
Adults 18 to 90, any sex, with Common Bile Duct Calculi or Acute; Cholecystitis, Choledocholithiasis. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The modified laparoscopic transcystic biliary drainage which we developed in the treatment of cholecystocholedocholithiasis has some advantages over conventional techniques. Here, a 7-Fr triple-lumen 30-cm central venous catheter was adopted to replace conventional 5-Fr ureteral catheter, which extended the function of the C-tube. Then we developed a continued suture and circling manner by the V-Loc closure device, which simultaneously covered and anchored the C-tube. Theoretically, this modified laparoscopic transcystic drainage not only provide safe and effective bile duct drainage, but also provide a convenient access of treatment for postoperatively retained bile duct stones, which may expand the indication of initially laparoscopic operation in the management of cholecysto-choledocholithiasis.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Safety and effectiveness of modified laparoscopic transcystic biliary drainage in the treatment of choledocholithiasis: study protocol for a prospective single-arm clinical trial.
Zhang YY, Wang G, Hou C, Xu Z, et al · · 2025 · PMID 40268483 · DOI 10.1136/bmjopen-2024-089540
Verify or expand the search:
- PubMed search for NCT06011941
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Common Bile Duct Calculi
Currently open trials in the same condition.
- NCT07008170 — Laparoendoscopic Rendezvous for Concomitant Gall Bladder Stones and Common Bile Duct Stones · NA · recruiting
Other Peking University Third Hospital trials
Trials by the same sponsor.
- NCT07532421 — Probiotic Intervention on the Development of Allergic Diseases in Infants Exposed to Antibiotics Early in Life · NA · not yet recruiting
- NCT07470255 — Detection of Diabetic Foot Skin Damage Using Plantar Mechanical Parameters · not yet recruiting
- NCT07453381 — Multisensor Wireless Pressure Microcatheter For Microvascular Function Assessment In ANOCA/INOCA Patients: A Prospective · not yet recruiting
- NCT07452354 — AI-Based Diabetic Foot Recurrence Cohort · not yet recruiting
- NCT07423819 — Sports Rehabilitation Therapy for Knee Joint Sports Injuries: A Case Study of Anterior Cruciate Ligament Injury and Pate · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06011941 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Peking University Third Hospital
- Last refreshed: 25 August 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06011941.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing